BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23518499)

  • 21. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.
    Delva L; Cornic M; Balitrand N; Guidez F; Micléa JM; Delmer A; Teillet F; Fenaux P; Castaigne S; Degos L
    Blood; 1993 Oct; 82(7):2175-81. PubMed ID: 8400267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
    Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q
    Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATRA and the specific RARα agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells.
    Chee LC; Hendy J; Purton LE; McArthur GA
    Leukemia; 2013 Jun; 27(6):1369-80. PubMed ID: 23228968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.
    Rashid A; Duan X; Gao F; Yang M; Yen A
    Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
    Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
    Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.
    Chen Q; Ross AC
    Exp Cell Res; 2004 Jul; 297(1):68-81. PubMed ID: 15194426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.
    García-Gutiérrez L; Bretones G; Molina E; Arechaga I; Symonds C; Acosta JC; Blanco R; Fernández A; Alonso L; Sicinski P; Barbacid M; Santamaría D; León J
    Sci Rep; 2019 Dec; 9(1):18693. PubMed ID: 31822694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trametinib enhances ATRA-induced differentiation in AML cells.
    Lu H; Li ZY; Ding M; Liang C; Weng XQ; Sheng Y; Wu J; Cai X
    Leuk Lymphoma; 2021 Dec; 62(14):3361-3372. PubMed ID: 34355652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDK2 suppression synergizes with all-trans-retinoic acid to overcome the myeloid differentiation blockade of AML cells.
    Shao X; Xiang S; Fu H; Chen Y; Xu A; Liu Y; Qi X; Cao J; Zhu H; Yang B; He Q; Ying M
    Pharmacol Res; 2020 Jan; 151():104545. PubMed ID: 31740384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia.
    Wang H; Zheng X; Behm FG; Ratnam M
    Blood; 2000 Nov; 96(10):3529-36. PubMed ID: 11071651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
    Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
    Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways.
    Glasow A; Prodromou N; Xu K; von Lindern M; Zelent A
    Blood; 2005 Jan; 105(1):341-9. PubMed ID: 15339853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
    Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
    Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
    Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD
    Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.
    Steinmetz B; Hackl H; Slabáková E; Schwarzinger I; Smějová M; Spittler A; Arbesu I; Shehata M; Souček K; Wieser R
    Cell Cycle; 2014; 13(18):2931-43. PubMed ID: 25486480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation.
    Miftakhova R; Sandberg T; Hedblom A; Nevzorova T; Persson JL; Bredberg A
    Anticancer Res; 2012 Nov; 32(11):4715-22. PubMed ID: 23155234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines.
    Grande A; Montanari M; Manfredini R; Tagliafico E; Zanocco-Marani T; Trevisan F; Ligabue G; Siena M; Ferrari S; Ferrari S
    Cell Death Differ; 2001 Jan; 8(1):70-82. PubMed ID: 11313705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.